Colon Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colon Cancer, including details on causes, treatment, symptoms.

Volume 2 (2005), Issue 4 (April)

1. Radiofrequency ablation therapy of remnant colorectal liver metastases after a course of hepatic arterial infusion chemotherapy.
   J Vasc Interv Radiol, 16(4): 549-54. [Abstract] [Full-text]
2. Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice.
   Neoplasia, 7(2): 118-27. [Abstract] [Full-text]
3. Eradication of tumors from a human colon cancer cell line and from ovarian cancer metastases in immunodeficient mice by a single-chain Ep-CAM-/CD3-bispecific antibody construct.
   Cancer Res, 65(7): 2882-9. [Abstract] [Full-text]
4. Cytoplasmic phospholipase A2 deletion enhances colon tumorigenesis.
   Cancer Res, 65(7): 2636-43. [Abstract] [Full-text]
5. A substantial proportion of microsatellite-unstable colon tumors carry TP53 mutations while not showing chromosomal instability.
   Genes Chromosomes Cancer, 43(2): 194-201. [Abstract] [Full-text]
6. Meat consumption and K-ras mutations in sporadic colon and rectal cancer in The Netherlands Cohort Study.
   Br J Cancer, 92(7): 1310-20. [Abstract] [Full-text]
7. Proximal location of colon cancer is a risk factor for development of metachronous colorectal cancer: a population-based study.
   Dis Colon Rectum, 48(2): 227-32. [Abstract] [Full-text]
8. Advantage of a residualizing iodine radiolabel in the therapy of a colon cancer xenograft targeted with an anticarcinoembryonic antigen monoclonal antibody.
   Clin Cancer Res, 11(7): 2727-34. [Abstract] [Full-text]
9. Age and manifestation related symptoms in familial adenomatous polyposis.
   BMC Cancer, 5: 24. [Abstract] [Full-text]
10. Microsatellite instability of selective target genes in HNPCC-associated colon adenomas.
    Oncogene, 24(15): 2525-35. [Abstract] [Full-text]
11. The guanine nucleotide exchange factor Tiam1 increases colon carcinoma growth at metastatic sites in an orthotopic nude mouse model.
    Oncogene, 24(15): 2568-73. [Abstract] [Full-text]
12. Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription.
    Exp Cell Res, 305(2): 300-11. [Abstract] [Full-text]
13. Purification of cyclotron-produced 203Pb for labeling Herceptin.
    Nucl Med Biol, 32(3): 301-5. [Abstract] [Full-text]
14. Effects of black grape extract on activities of DNA turn-over enzymes in cancerous and non cancerous human colon tissues.
    Life Sci, 76(25): 2995-3000. [Abstract] [Full-text]
15. A prospective study of outcomes of emergency and elective surgeries for complicated colonic cancer.
    Am J Surg, 189(4): 377-83. [Abstract] [Full-text]
16. The GADD45, ZBRK1 and BRCA1 pathway: quantitative analysis of mRNA expression in colon carcinomas.
    J Pathol, 206(1): 92-9. [Abstract] [Full-text]
17. Cell turnover of serrated adenomas.
    J Pathol, 206(1): 62-7. [Abstract] [Full-text]
18. APC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma.
    Cancer Epidemiol Biomarkers Prev, 14(4): 863-70. [Abstract] [Full-text]
19. Chemoprevention: mouse colon and lung tumor bioassay and modulation of DNA methylation as a biomarker.
    Exp Lung Res, 31(2): 145-63. [Abstract] [Full-text]
20. Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion.
    Int J Colorectal Dis, 20(3): 258-61. [Abstract] [Full-text]
21. Structural and numerical chromosome changes in colon cancer develop through telomere-mediated anaphase bridges, not through mitotic multipolarity.
    Proc Natl Acad Sci U S A, 102(15): 5541-6. [Abstract] [Full-text]
22. Bile acids induce MUC2 overexpression in human colon carcinoma cells.
    Cancer, 103(8): 1606-14. [Abstract] [Full-text]
23. Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals.
    Int J Cancer, 115(3): 437-42. [Abstract] [Full-text]
24. Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma: clinical evidence for immunoselection and CD95L mediated control of minimal residual disease.
    Gut, 54(5): 661-5. [Abstract] [Full-text]
25. Increased microvascular blood content is an early event in colon carcinogenesis.
    Gut, 54(5): 654-60. [Abstract] [Full-text]
26. Associations in breast and colon cancer screening behavior in women.
    Acad Radiol, 12(4): 451-8. [Abstract] [Full-text]
27. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance.
    Cancer Res, 65(8): 3162-70. [Abstract] [Full-text]
28. Changes over time in thymidine phosphorylase and dihydropyrimidine dehydrogenase when colon cancer samples are left at room temperature.
    Cancer Lett, 222(1): 107-12. [Abstract] [Full-text]
29. Identification of sentinel nodes in patients with colon cancer.
    Eur J Surg Oncol, 31(4): 381-5. [Abstract] [Full-text]
30. Cyclooxygenase-2 regulation in colon cancer cells: modulation of RNA polymerase II elongation by histone deacetylase inhibitors.
    J Biol Chem, 280(16): 15503-9. [Abstract] [Full-text]
31. Cigarette smoking and colorectal cancer: APC mutations, hMLH1 expression, and GSTM1 and GSTT1 polymorphisms.
    Am J Epidemiol, 161(9): 806-15. [Abstract] [Full-text]
32. Ileocolonic lymphomas: a series of 16 cases.
    Endoscopy, 37(5): 466-9. [Abstract] [Full-text]
33. alpha-Lipoic acid induces apoptosis in human colon cancer cells by increasing mitochondrial respiration with a concomitant O2-*-generation.
    Apoptosis, 10(2): 359-68. [Abstract] [Full-text]
34. Characterization of macrophage subpopulations in colon cancer using tissue microarrays.
    Histopathology, 46(5): 515-21. [Abstract] [Full-text]
35. Risk of colorectal neoplasm in patients with acromegaly and its relationship with serum growth hormone levels.
    Am J Gastroenterol, 100(5): 1154-60. [Abstract] [Full-text]
36. Adenomas in young patients: what is the optimal evaluation?
    Am J Gastroenterol, 100(5): 1150-3. [Abstract] [Full-text]
37. Low rate of microsatellite instability in young patients with adenomas: reassessing the Bethesda guidelines.
    Am J Gastroenterol, 100(5): 1143-9. [Abstract] [Full-text]
38. Successful desensitization to oxaliplatin.
    Ann Pharmacother, 39(5): 966-9. [Abstract] [Full-text]
39. Colorectal cancer in two pre-teenage siblings with familial adenomatous polyposis.
    Eur J Pediatr, 164(5): 306-10. [Abstract] [Full-text]
40. Phase II study of irinotecan, 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer.
    Jpn J Clin Oncol, 35(4): 214-7. [Abstract] [Full-text]
41. Combined inhibition of extracellular signal-regulated kinases and HSP90 sensitizes human colon carcinoma cells to ionizing radiation.
    Oncogene, 24(18): 3011-9. [Abstract] [Full-text]
42. Absence of acute apoptotic response to genotoxic carcinogens in p53-deficient mice is associated with increased susceptibility to azoxymethane-induced colon tumours.
    Int J Cancer, 115(4): 561-7. [Abstract] [Full-text]
43. Casein kinase 2- and protein kinase A-regulated adenomatous polyposis coli and beta-catenin cellular localization is dependent on p38 MAPK.
    J Biol Chem, 280(17): 17221-6. [Abstract] [Full-text]
44. Imaging of single human carcinoma cells in vitro using a clinical whole-body magnetic resonance scanner at 3.0 T.
    Magn Reson Med, 53(5): 1187-92. [Abstract] [Full-text]
45. Clinical significance of microsatellite instability in the inflamed mucosa for the prediction of colonic neoplasms in patients with ulcerative colitis.
    J Gastroenterol Hepatol, 20(5): 710-5. [Abstract] [Full-text]
46. Allogeneic dendritomas induce anti-tumour immunity against metastatic colon cancer.
    Scand J Immunol, 61(4): 364-9. [Abstract] [Full-text]
47. G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the {beta}-catenin pathway.
    Proc Natl Acad Sci U S A, 102(17): 6027-32. [Abstract] [Full-text]
48. Robust estimation of protein expression ratios with lysate microarray technology.
    Bioinformatics, 21(9): 1935-42. [Abstract] [Full-text]
49. 5-Fluorouracil/irinotecan induced lethal toxicity as a result of a combined pharmacogenetic syndrome: report of a case.
    J Clin Pathol, 58(5): 553-5. [Abstract] [Full-text]
50. Expression of secreted Wnt antagonists in gastrointestinal tissues: potential role in stem cell homeostasis.
    J Clin Pathol, 58(5): 515-9. [Abstract] [Full-text]
51. Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome.
    J Clin Pathol, 58(5): 509-14. [Abstract] [Full-text]
52. Predictive testing for hereditary nonpolyposis colorectal cancer: subjective perception regarding colorectal and endometrial cancer, distress, and health-related behavior at one year post-test.
    Genet Test, 9(1): 54-65. [Abstract] [Full-text]
53. APC germ-line mutations in southern Spanish patients with familial adenomatous polyposis: genotype-phenotype correlations and identification of eight novel mutations.
    Genet Test, 9(1): 37-40. [Abstract] [Full-text]
54. False-negative results at multi-detector row CT colonography: multivariate analysis of causes for missed lesions.
    Radiology, 235(2): 495-502. [Abstract] [Full-text]
55. Array-based analysis of genomic DNA methylation patterns of the tumour suppressor gene p16INK4A promoter in colon carcinoma cell lines.
    Nucleic Acids Res, 33(8): e73. [Abstract] [Full-text]

© 2004-2008 Colon Cancer Research Today. All Rights Reserved.